Blood-based biomarkers for Alzheimer’s are simpler, cheaper and less invasive than methods used currently. Their greater accessibility could improve the timeliness of diagnosis and care. Produced by Nature Research Custom Media Lucent Diagnostics Blood biomarkers are obtained from a simple blood sample, making them less invasive than other methods for detecting AD pathology.Credit: stefanamer/iStock/Getty “It’s...
Medscape Medical News Megan Brooks August 14, 2024 BRCA1 and BRCA2 pathogenic variants carry well-known associations with breast and ovarian cancers in women, which has led to robust clinical guidelines for early genetic testing and risk-reduction strategies. Male carriers of BRCA1/2 pathogenic variants also face an increased risk for cancer, particularly of the prostate, pancreas,...
August 12, 2024 by NIH/National Heart, Lung and Blood Institute Credit: Pixabay/CC0 Public DomainA National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition. The study, part of NIH’s Researching COVID to Enhance Recovery (NIH...
News Release 8-Aug-2024 Peer-Reviewed PublicationUniversity of Virginia Health System image: “We hope this discovery will stimulate further work in the treatment of recurrent wheeze and viral infections in children,” said researcher W. Gerald Teague, MD, a pediatric pulmonologist at UVA Health Children’s and the University of Virginia School of Medicine. “The field has to get...
August 12, 2024 by Yale School of Medicine Credit: Pixabay/CC0 Public DomainA Yale School of Medicine team reports in a new study that an artificial intelligence (AI) model was able to reliably diagnose people living with Marfan syndrome from a simple facial photograph. Marfan syndrome is a genetic disorder, affecting about 1 in 3,000 people,...
News Release 9-Aug-2024 Glycopeptide probes detect tumor-associated antibodies in blood samples Peer-Reviewed PublicationWiley Pancreatic cancer is one of the most lethal forms of cancer, primarily because it is usually diagnosed very late. Current markers are too insensitive and unspecific for early detection screenings. In the journal Angewandte Chemie, a research team has now introduced a...
August 7, 2024 by British Medical Journal Credit: Karolina Grabowska from PexelsNew evidence published by The BMJ today casts doubt on a much-hyped blood test for the NHS that promises to detect more than 50 types of cancer. The test, called Galleri, has been hailed as a “ground-breaking and potentially life-saving advance” by its maker,...
A commercially available blood test did a better job of detecting Alzheimer’s disease than primary care doctors or specialists using traditional tools, according to findings from a large study. Patients being evaluated for cognitive problems were tested with C2N Diagnostics’ PrecivityAD2 blood test, which looks for fragments of amyloid beta and tau proteins known to...
July 30, 2024 by Washington University School of Medicine Determining performance of blood biomarker tests for amyloid pathology.Neurologists diagnose cognitive impairment with a clinical exam of memory and thinking skills. To determine whether Alzheimer’s disease is the cause of the cognitive impairment, evidence of the specific brain changes that characterize Alzheimer’s must be obtained, typically...
NEWS RELEASE 23-JUL-2024 A Rutgers Health physician-scientist publishes guidance for primary care doctors diagnosing and treating early Lyme disease, a bacterial infection Peer-Reviewed PublicationRUTGERS UNIVERSITY Every year in the United States, an estimated 476,000 people are diagnosed and treated for Lyme disease. The estimate comes from the U.S. Centers for Disease Control and Prevention (CDC)....
